You are here

Identifying strategies for individualized brain stimulation for Major Depressive Disorder

Identifying strategies for individualized brain stimulation for Major Depressive Disorder

Event Date: 
Wednesday, May 13, 2020
Event Location: 
Webinar

 

In this webinar, we are happy to introduce TMS brain stimulation strategies for optimized MDD treatment.

Standard 10 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) is an effective treatment for Major Depressive Disorder (MDD) with response rates between 30-40%. We show that rTMS-induced changes in functional brain connectivity can predict clinical outcome and that the proximity of the individual alpha frequency to the stimulation frequency is associated with better clinical outcome. We will present a procedure developed for the interrogation of frequencies between 3 – 17 Hz to identify the optimal stimulation frequency for MDD treatment. Individualized brain stimulation is highly promising for increasing clinical response rates. Biomarkers and early response predictors are critical in developing the appropriate stimulation strategy. The presenter is Dr. Juliana Corlier who received her Ph.D in Cognitive Neuroscience from the Sorbonne Universities in Paris, France. Dr. Corlier has completed her postdoctoral training at the UCLA Neuromodulation Division under the supervision of Dr. Andrew Leuchter. In her current work as an assistant project scientist, she oversees projects that combine neuronavigated TMS, simultaneous EEG recordings and multimodal neuroimaging, focusing on the development of biomarkers and individualized stimulation approaches to TMS treatment. This session will be followed by a live demonstration of a navigated TMS setup by ANT Neuro application specialist/ product management team.

The registration will be open till 11.05.2020 (24:00 CET), and the confirmations will be sent out the day after.

© Copyright 1999 - 2020 ANT Neuro | www.ant-neuro.com | Terms of Use | Privacy Statement | Contact | USA Customers